Impact of Seizure Frequency Reduction on Health-Related Quality of Life Among Clinical Trial Subjects with Refractory Partial-Onset Seizures: A Pooled Analysis of Phase Iii Clinical Trials of Eslicarbazepine Acetate
AuthID
P-00M-MHF
P-00M-MHF